Turnstone Biologics Corp. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 19.63 million compared to net income of USD 0.068 million a year ago.

Basic loss per share from continuing operations was USD 0.85.